222 related articles for article (PubMed ID: 30032834)
1. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
Goyal G; Kommalapati A; Bartley AC; Gunderson TM; Adjei AA; Go RS
Lung Cancer; 2018 Aug; 122():214-219. PubMed ID: 30032834
[TBL] [Abstract][Full Text] [Related]
2. Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma.
Go RS; Bartley AC; Crowson CS; Shah ND; Habermann EB; Holton SJ; Holmes DR
J Clin Oncol; 2017 Feb; 35(6):598-604. PubMed ID: 28199819
[TBL] [Abstract][Full Text] [Related]
3. Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.
Go RS; Al-Hamadani M; Shah ND; Crowson CS; Holton SJ; Habermann EB
Cancer; 2016 Aug; 122(16):2552-9. PubMed ID: 27182831
[TBL] [Abstract][Full Text] [Related]
4. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
Kommalapati A; Tella SH; Appiah AK; Smith L; Ganti AK
J Natl Compr Canc Netw; 2019 Mar; 17(3):229-236. PubMed ID: 30865920
[TBL] [Abstract][Full Text] [Related]
5. Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy.
Morgensztern D; Ko A; O'Brien M; Ong TJ; Waqar SN; Socinski MA; Postmus PE; Bhore R
Cancer; 2019 Jul; 125(14):2394-2399. PubMed ID: 30933354
[TBL] [Abstract][Full Text] [Related]
6. Hospital lung surgery volume and patient outcomes.
Thai AA; Stuart E; Te Marvelde L; Milne RL; Knight S; Whitfield K; Mitchell P
Lung Cancer; 2019 Mar; 129():22-27. PubMed ID: 30797487
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
Steuer CE; Behera M; Liu Y; Fu C; Gillespie TW; Saba NF; Shin DM; Pillai RN; Pakkala S; Owonikoko TK; Khuri FR; Ramalingam SS
Clin Lung Cancer; 2017 May; 18(3):286-292. PubMed ID: 28043773
[TBL] [Abstract][Full Text] [Related]
8. Variable impact of prior cancer history on the survival of lung cancer patients.
Monsalve AF; Hoag JR; Resio BJ; Chiu AS; Brown LB; Detterbeck FC; Blasberg JD; Boffa DJ
Lung Cancer; 2019 Jan; 127():130-137. PubMed ID: 30642541
[TBL] [Abstract][Full Text] [Related]
9. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
10. Patient and Facility Demographics Related Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated with Radiofrequency Ablation: A National Cancer Database Analysis.
Lam A; Yoshida EJ; Bui K; Katrivesis J; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Nov; 29(11):1535-1541.e2. PubMed ID: 30293735
[TBL] [Abstract][Full Text] [Related]
11. Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.
Mulvihill MS; Cox ML; Becerra DC; Watson JA; Voigt SL; Yerokun BA; Speicher PJ; D'Amico TA; Tong B; Hartwig MG
Ann Thorac Surg; 2018 Nov; 106(5):1533-1540. PubMed ID: 29959940
[TBL] [Abstract][Full Text] [Related]
12. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer.
Wang EH; Rutter CE; Corso CD; Decker RH; Wilson LD; Kim AW; Yu JB; Park HS
J Thorac Oncol; 2015 Jun; 10(6):937-43. PubMed ID: 25738221
[TBL] [Abstract][Full Text] [Related]
13. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
Heilbroner SP; Xanthopoulos EP; Buono D; Huang Y; Carrier D; Shah A; Kim J; Corradetti M; Wright JD; Neugut AI; Hershman DL; Cheng SK
Lung Cancer; 2019 Mar; 129():8-15. PubMed ID: 30797496
[TBL] [Abstract][Full Text] [Related]
14. Type and case volume of health care facility influences survival and surgery selection in cases with early-stage non-small cell lung cancer.
Wang S; Lai S; von Itzstein MS; Yang L; Yang DM; Zhan X; Xiao G; Halm EA; Gerber DE; Xie Y
Cancer; 2019 Dec; 125(23):4252-4259. PubMed ID: 31503336
[TBL] [Abstract][Full Text] [Related]
15. Travelling to a High-Volume Center Confers Improved Survival in Stage I Non-small Cell Lung Cancer.
Muslim Z; Baig MZ; Weber JF; Connery CP; Bhora FY
Ann Thorac Surg; 2022 Feb; 113(2):466-472. PubMed ID: 33662314
[TBL] [Abstract][Full Text] [Related]
16. Association between facility volume and mortality of patients with classic Hodgkin lymphoma.
Goyal G; Tella SH; Funni S; Kommalapati A; Inselman JW; Shah ND; Go RS; Ansell SM
Cancer; 2020 Feb; 126(4):757-764. PubMed ID: 31714588
[TBL] [Abstract][Full Text] [Related]
17. The Academic Facility Type Is Associated With Improved Overall Survival for Early-Stage Lung Cancer.
Merritt RE; Abdel-Rasoul M; Fitzgerald M; D'Souza DM; Kneuertz PJ
Ann Thorac Surg; 2021 Jan; 111(1):261-268. PubMed ID: 32615092
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
19. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
20. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
